NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00002822,Combination Chemotherapy Followed by Radiation Therapy in Patients With Small Cell Lung Cancer,https://clinicaltrials.gov/study/NCT00002822,,COMPLETED,"RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug is a way to kill more tumor cells. Combining radiation therapy with chemotherapy may kill more tumor cells.

PURPOSE: Randomized phase III trial to compare the effect of two combination chemotherapy regimens followed by radiation therapy in treating patients with small cell lung cancer.",NO,Lung Cancer,DRUG: carboplatin|DRUG: cisplatin|DRUG: cyclophosphamide|DRUG: doxorubicin hydrochloride|DRUG: etoposide|DRUG: ifosfamide|DRUG: mesna|DRUG: vincristine sulfate|RADIATION: radiation therapy,,,,Medical Research Council,,ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,400,OTHER_GOV,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT,CDR0000064998|MRC-LU21|EU-96019,1996-03,,2005-11,2003-04-16,,2013-12-19,"Medical Research Council Clinical Trials Unit, London, England, NW1 2DA, United Kingdom",
